Green Leaf Medical AB (Stockholm) has patented a production process for spinach-derived thylakoids, which the company claims can promote appetite suppression.
Green Leaf Medical AB (Stockholm) has patented a production process for spinach-derived thylakoids, which the company claims can promote appetite suppression.
Thylakoids are membrane-bound compartments found inside the chloroplasts of plant cells. According to Green Leaf, in vitro and in vivo studies indicate that these substances can prevent fat and carbohydrate assimilation and promote appetite reduction for at least six hours.
While the company is planning long-term studies for 2011 and 2012 and preparing for US and EU regulatory processes, Green Leaf says that it will have a market-ready product by 2012. The company continues to explore its ingredient for use in dietary supplements, functional foods, and beverages.
Judge in CRN’s complaint against NY denies the State’s motion to dismiss
Published: May 14th 2024 | Updated: May 15th 2024New York State's motion to dismiss CRN's lawsuit against the law banning the sale of weight management and muscle-building supplements to minors has been partially denied, allowing CRN to proceed with its First Amendment Claim.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
CRN NY State lawsuit update: Dispatch from SupplySide East 2024
April 18th 2024CRN's Steve Mister updates Nutritional Outlook about its ongoing litigation against NY State. The organization sued the state to prevent the enforcement of law that bans sale of weight management supplements to minors.